Skip to main content

Advertisement

SpringerLink
Log in

Response to traditional disease-modifying anti-rheumatic drugs in indigent South Africans with early rheumatoid arthritis

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The clinical response to traditional disease-modifying anti-rheumatic drugs (DMARDs) in indigent South Africans with early rheumatoid arthritis was investigated. A cohort of patients with early (≤2 years) RA who were DMARD-naïve at inception were prospectively assessed for response to DMARDs using the Simplified Disease Activity Index (SDAI) over a 12-month period. Patients with low disease activity (LDA) at 12 months were compared to those with moderate and high disease activity with respect to demographic, clinical, autoantibody and radiographic features. The 171 patients (140 females) had a mean (SD) age of 47.1 (12.4) years, symptom duration of 11.7 (7.1) months and baseline SDAI of 39.4 (16.2). There was a significant overall improvement in the SDAI and its components in the 134 (78.4%) patients who completed the 12 months visit, but only 28.4% of them achieved LDA. The majority of patients (91%) were treated with methotrexate as monotherapy or in combination with chloroquine and/or sulphasalazine. Baseline features that independently predicted a LDA state at 12 months were lower Health Assessment Questionnaire Disability Index (p = 0.023) and a higher haemoglobin level (p = 0.048). Receiver operating characteristic curve analysis showed that the 6-month SDAI was better than the baseline SDAI in predicting the 12-month SDAI (area under the curve of 0.69 vs. 0.52, respectively, p = 0.008). In conclusion, less than a third of the patients achieved a low disease activity at 12 months on traditional DMARDs. Patients who have an inadequate response to traditional DMARDs at 6 months are unlikely to show further improvement on traditional DMARDs at 12 months. These findings underscore the need for better disease control by an aggressive tight control strategy, including intense patient education and biologic therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Smolen JS, Aletaha D, Machold KP (2005) Therapeutic strategies in early rheumatoid arthritis. Best Pract Res Clin Rheumatol 19:163–177

    Article  PubMed  CAS  Google Scholar 

  2. Quinn MA, Cox S (2005) The evidence for early intervention. Rheum Dis Clin North Am 31:575–589

    Article  PubMed  Google Scholar 

  3. Morel J, Combe B (2005) How to predict prognosis in early rheumatoid arthritis. Best Pract Res Clin Rheumatol 19:137–146

    Article  PubMed  CAS  Google Scholar 

  4. Mayosi BM, Flisher AJ, Lalloo UG et al (2009) The burden of non-communicable diseases in South Africa. Lancet 374:934–947

    Article  PubMed  Google Scholar 

  5. Beaglehole R, Bonita R, Horton R et al (2011) Priority actions for the non-communicable disease crisis. Lancet 377:1438–1447

    Article  PubMed  Google Scholar 

  6. Tikly M, Zannettou N, Hopley M (2003) A longitudinal study of rheumatoid arthritis in South Africans. MedGenMed 5:2

    PubMed  Google Scholar 

  7. Solomon A, Christian BF, Dessein PH et al (2005) The need for tighter rheumatoid arthritis control in a South African public health care center. Semin Arthritis Rheum 35:122–131

    Article  PubMed  Google Scholar 

  8. Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324

    Article  PubMed  CAS  Google Scholar 

  9. Kirwan JR, Reeback JS (1986) Stanford Health Assessment Questionnaire modified to assess disability in British patients with rheumatoid arthritis. Br J Rheumatol 25:206–209

    Article  PubMed  CAS  Google Scholar 

  10. Organisation WH (1968) Nutritional anaemias: report of a WHO Scientific Group. World Health Organ Tech Rep Ser 405:5–37

    Google Scholar 

  11. Aletaha D, Smolen J (2005) The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol 23:S100–S108

    PubMed  CAS  Google Scholar 

  12. Rau R, Herborn G (1995) A modified version of Larsen's scoring method to assess radiologic changes in rheumatoid arthritis. J Rheumatol 22:1976–1982

    PubMed  CAS  Google Scholar 

  13. Saevarsdottir S, Wallin H, Seddighzadeh M et al (2011) Predictors of response to methotrexate in early DMARD naive rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial. Ann Rheum Dis 70:469–475

    Article  PubMed  Google Scholar 

  14. Khanna D, Oh M, Furst DE et al (2007) Evaluation of the preliminary definitions of minimal disease activity and remission in an early seropositive rheumatoid arthritis cohort. Arthritis Rheum 57:440–447

    Article  PubMed  Google Scholar 

  15. Harrison MJ, Tricker KJ, Davies L et al (2005) The relationship between social deprivation, disease outcome measures, and response to treatment in patients with stable, long-standing rheumatoid arthritis. J Rheumatol 32:2330–2336

    PubMed  Google Scholar 

  16. Vliet Vlieland TP, Buitenhuis NA, van Zeben D (1994) Sociodemographic factors and the outcome of rheumatoid arthritis in young women. Ann Rheum Dis 53:803–806

    Article  PubMed  CAS  Google Scholar 

  17. Sokka T, Kautiainen H, Toloza S et al (2007) QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries. Ann Rheum Dis 66:1491–1496

    Article  PubMed  Google Scholar 

  18. Drossaers-Bakker KW, Zwinderman AH, Vliet Vlieland TP et al (2002) Long-term outcome in rheumatoid arthritis: a simple algorithm of baseline parameters can predict radiographic damage, disability, and disease course at 12-year followup. Arthritis Rheum 47:383–390

    Article  PubMed  CAS  Google Scholar 

  19. Gossec L, Dougados M, Goupille P et al (2004) Prognostic factors for remission in early rheumatoid arthritis: a multiparameter prospective study. Ann Rheum Dis 63:675–680

    Article  PubMed  CAS  Google Scholar 

  20. Furst DE, Chang H, Greenberg JD et al (2009) Prevalence of low hemoglobin levels and associations with other disease parameters in rheumatoid arthritis patients: evidence from the CORRONA registry. Clin Exp Rheumatol 27:560–566

    PubMed  CAS  Google Scholar 

  21. Raj DS (2009) Role of interleukin-6 in the anemia of chronic disease. Semin Arthritis Rheum 38:382–388

    Article  PubMed  CAS  Google Scholar 

  22. Farr M, Scott DL, Constable TJ et al (1983) Thrombocytosis of active rheumatoid disease. Ann Rheum Dis 42:545–549

    Article  PubMed  CAS  Google Scholar 

  23. Ertenli I, Haznedaroglu IC, Kiraz S et al (1996) Cytokines affecting megakaryocytopoiesis in rheumatoid arthritis with thrombocytosis. Rheumatol Int 16:5–8

    Article  PubMed  CAS  Google Scholar 

  24. Aletaha D, Funovits J, Keystone EC et al (2007) Disease activity early in the course of treatment predicts response to therapy after one year in rheumatoid arthritis patients. Arthritis Rheum 56:3226–3235

    Article  PubMed  CAS  Google Scholar 

  25. Grigor C, Capell H, Stirling A et al (2004) Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 364:263–269

    Article  PubMed  Google Scholar 

  26. Rantalaiho V, Korpela M, Laasonen L et al (2010) Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial. Arthritis Res Ther 12:R122

    Article  PubMed  Google Scholar 

  27. van der Kooij SM, de Vries-Bouwstra JK, Goekoop-Ruiterman YP et al (2007) Limited efficacy of conventional DMARDs after initial methotrexate failure in patients with recent onset rheumatoid arthritis treated according to the disease activity score. Ann Rheum Dis 66:1356–1362

    Article  PubMed  Google Scholar 

  28. van der Helm-van Mil AH, Verpoort KN, Breedveld FC (2005) Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res Ther 7:R949–R958

    Article  PubMed  Google Scholar 

  29. Jawaheer D, Maranian P, Park G et al (2010) Disease progression and treatment responses in a prospective DMARD-naive seropositive early rheumatoid arthritis cohort: does gender matter? J Rheumatol 37:2475–2485

    Article  PubMed  Google Scholar 

  30. Papadopoulos NG, Alamanos Y, Voulgari PV et al (2005) Does cigarette smoking influence disease expression, activity and severity in early rheumatoid arthritis patients? Clin Exp Rheumatol 23:861–866

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

Funding for this study was obtained from the Connective Tissue Diseases Research Fund, University of the Witwatersrand and the Medical Research Council of South Africa.

Disclosures

None.

Author information

Authors and Affiliations

  1. Division of Rheumatology, Department of Medicine, Chris Hani Baragwanath Hospital, University of the Witwatersrand, PO Box Bertsham 2013, Johannesburg, South Africa

    B. Hodkinson & M. Tikly

  2. Biostatistics and Epidemiology Division, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

    E. Musenge

  3. Department Internal Medicine, University of Pretoria, Pretoria, South Africa

    M. Ally

  4. Medical Research Council Unit for Inflammation and Immunity, Department of Immunology, Faculty of Health Sciences, University of Pretoria, and Tshwane Academic Division of the National Health Laboratory Service, Pretoria, South Africa

    P. W. A. Meyer & R. Anderson

  5. NHLS–Tshwane Academic Division, Pretoria, South Africa

    R. Anderson

Authors
  1. B. Hodkinson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Musenge
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Ally
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. W. A. Meyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Anderson
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Tikly
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B. Hodkinson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hodkinson, B., Musenge, E., Ally, M. et al. Response to traditional disease-modifying anti-rheumatic drugs in indigent South Africans with early rheumatoid arthritis. Clin Rheumatol 31, 613–619 (2012). https://doi.org/10.1007/s10067-011-1900-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-011-1900-5

Keywords

Search

Navigation